The trademark application NYRLUQ was filed by Orasis Pharmaceuticals Ltd., a corporation established under the laws of the State of Israel (the "Applicant"). The application was published for oppositions on October 10, 2022, and it was registered by office on January 17, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on May 25, 2023. Appointment and Replacement of representative of the trademark registration was recorded on February 11, 2024.